PARIS (dpa-AFX) - A phase II trial of investigational antibiotic
Solithromycin in Japanese patients with community acquired bacterial pneumonia
or CABP in short, conducted by Cempra Inc.'s (CEMP) partner Toyama Chemical has
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) announced that the Endocrinologic and
Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug
Administration (FDA) recommended the approval of the New Drug Application or NDA
By Matthias Blamont and Noëlle Mennella
PARIS (Reuters) - Sanofi will step up its push into China, its second biggest market after the United States, in the next five years as part of a wider expansion into emerging countries, where it sees a...